Determining Excreted Drug Dangers under USP 800

Why Should You Attend:

Do you know that Entities that handle HD’s must incorporate the standards of USP chapter 800 into their occupational safety plan? Each entity must have a “designated person responsible for compliance”.

When developing a comprehensive hazardous drug handling plan it is important to know which drugs need to be controlled as they are exiting the patient’s body. This training will help in developing the plan as a requirement of USP 800. We will discuss the safe collection and disposal of human waste as well as materials that came in contact with the drugs in the waste.

USP 800 takes control of some hazardous drugs outside the pharmacy walls. As many of you know some HD’s are excreted in the sweat saliva urine and feces. Control of exposure to the nurses handling the patient, people changing the linens as well as housekeeping need to be informed and protected.

This course will give a brief history of chemotherapy and why we need to protect people that handle these drugs even in the patient excretions. We will look at the development of the Niosh hazardous drug list and compare with the excretion data that is provided on the drug package insert. Most of the almost 300 hazardous drugs are not dangerous in the patient waste, we will look at the ones that are and how your pharmacy can decide which drugs need to be contained in the hospital setting and how to contain these drugs.

We will discuss other agencies that regulate the HD’s even in human waste and how to comply.

In this course you will learn how to evaluate your pharmacy formulary and decide what drugs will be managed in the excretions when developing a comprehensive HD program. This will help in understanding the personnel that will need training, personal protection equipment, medical monitoring and other provisions in USP 800.

Areas Covered in the Webinar:

• Identify the hazardous drugs that are dangerous when excreted
• Creating a list of excreted HD’s
• Setting a timeframe for how long containment will be required
• Identify hospital personnel that will be exposed, how they will be exposed and who will require protection under USP 800
• Identify areas that need to be monitored for contamination outside of the pharmacy
• Create protocols for handling bodily fluids (e.g., urine, feces, sweat or vomit) or body fluid contaminated clothing, dressings, linens and other materials.
• Setting up disposal options in compliance with OSHA standards, department transportation regulations as well as federal state and local rules and regulations.
• Implementing a comprehensive hazardous drug control, containment and disposal program that fits within the hospitals waste program.
• Learn about the policies of the World Health Organization, the joint commission on healthcare as well as others with similar recommendations
• Discuss ways for automatic notification of the excreted HD’s from the pharmacy to the nursing staff.
• Implementing reimbursement for control and disposal as part of the treatment with these excreted HD’s

Who Will Benefit:

• Chief pharmacist
• Head of safety
• USP 800 designated person
• Head of nursing
• CRN (Certified Registered Nurses)
• Environmental directors
• Risk managers
• Director of housekeeping
• Home healthcare
• Compliance Directors

From Cancer treatment centers, major hospitals, compounding pharmacies, home infusion companies, industrial cleaning companies

Jim Mullowney
President, Pharma Cycle Inc

Jim Mullowney has been specializing in the management of Extremely Hazardous Waste for more than 25 years focusing on Chemotherapy Drugs contained in human waste. He has presented to governmental agencies, Senators, Representatives, and Directors at large hospitals on the topic of drugs contained in urine, feces and vomit as extremely hazardous materials. Jim founded Pharma-Cycle, LLC. to provide awareness of the dangers to family posed by Chemotherapy drugs that have passed through the patient’s body and to provide a cost-effective solution.

Follow us :